Broich, Karl
Federal Institute for Drugs and Medical Devices
12 papers on CoChatORCID 0000-0002-7447-1206
Most cited papers
- Verified
Preclinical Alzheimer’s Disease: Definition, Natural History, and Diagnostic Criteria
Dubois, B., Hampel, H., Feldman, H. H., Scheltens, P., Aisen, P., Andrieu, S., Bakardjian, H., Benali, H., Bertram, L., Blennow, K., et al. (2016) · Alzheimer's & Dementia
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 1,925
- Verified
Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort study
Ehrt, U., Broich, K., Larsen, J. P., Ballard, C., & Aarsland, D. (2010) · Journal of Neurology, Neurosurgery & Psychiatry
Parkinson's Disease Mechanisms and TreatmentsPharmaceutical Practices and Patient Outcomes
Cited by 254
- Verified
A Precision Medicine Initiative for Alzheimer’s disease: the road ahead to biomarker-guided integrative disease modeling
Hampel, H., O’Bryant, S. E., Durrleman, S., Younesi, E., Rojkova, K., Escott-Price, V., Corvol, J.-C., Broich, K., Dubois, B., Lista, S., et al. (2017) · Climacteric
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 147
- Verified
Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force
Vellas, B., Carrillo, M. C., Sampaio, C., Brashear, H. R., Siemers, E., Hampel, H., Schneider, L. S., Weiner, M., Doody, R., Khachaturian, Z., et al. (2013) · Alzheimer's & Dementia
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 147
- Verified
Identification and validation of biomarkers for autism spectrum disorders
Loth, E., Spooren, W., Ham, L. M., Isaac, M. B., Auriche-Benichou, C., Banaschewski, T., Baron-Cohen, S., Broich, K., Bölte, S., Bourgeron, T., et al. (2016) · Nature Reviews Drug Discovery
Autism Spectrum Disorder ResearchGenetics and Neurodevelopmental Disorders
Cited by 140
- Verified
Suicidality and Risk of Suicide—Definition, Drug Safety Concerns, and a Necessary Target for Drug Development: A Consensus Statement
Meyer, R. E., Salzman, C., Youngstrom, E. A., Clayton, P. J., Goodwin, F. K., Mann, J. J., Alphs, L. D., Broich, K., Goodman, W. K., Greden, J. F., et al. (2010) · The Journal of Clinical Psychiatry
Suicide and Self-Harm StudiesBipolar Disorder and Treatment
Cited by 129
- Verified
Anticholinergic drug use and risk for dementia: target for dementia prevention
Jessen, F., Kaduszkiewicz, H., Daerr, M., Bickel, H., Pentzek, M., Riedel-Heller, S., Wagner, M., Weyerer, S., Wiese, B., van den Bussche, H., et al. (2010) · European Archives of Psychiatry and Clinical Neuroscience
Dementia and Cognitive Impairment ResearchPharmaceutical Practices and Patient Outcomes
Cited by 119
- Verified
Changes in regional cerebral blood flow by therapeutic vagus nerve stimulation in depression: an exploratory approach
Zobel, A., Joe, A., Freymann, N., Clusmann, H., Schramm, J., Reinhardt, M., Biersack, H.-J., Maier, W., & Broich, K. (2005) · Psychiatry Research: Neuroimaging
Vagus Nerve Stimulation ResearchTreatment of Major Depression
Cited by 117
- Verified
Altered Theta Oscillations and Aberrant Cortical Excitatory Activity in the 5XFAD Model of Alzheimer’s Disease
Siwek, M. E., Müller, R., Henseler, C., Trog, A., Lundt, A., Wormuth, C., Broich, K., Ehninger, D., Weiergräber, M., & Papazoglou, A. (2015) · Neural Plasticity
Alzheimer's disease research and treatmentsNeural dynamics and brain function
Cited by 71
- Verified
The road ahead to cure Alzheimer’s disease: development of biological markers and neuroimaging methods for prevention trials across all stages and target populations
Cavedo, E., Lista, S., Khachaturian, Z., Aisen, P., Amouyel, P., Herholz, K., Jack Jr, C. R., Sperling, R., Cummings, J., Blennow, K., et al. (2014) · The Journal of Prevention of Alzheimer's Disease
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 67
- Verified
Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline
Lista, S., Molinuevo, J. L., Cavedo, E., Rami, L., Amouyel, P., Teipel, S. J., Garaci, F., Toschi, N., Habert, M.-O., Blennow, K., et al. (2015) · Journal of Alzheimer's Disease
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 53
- Verified
The definition of treatment resistance in anxiety disorders: a Delphi method‐based consensus guideline
Domschke, K., Seuling, P. D., Schiele, M. A., Bandelow, B., Batelaan, N. M., Bokma, W. A., Branchi, I., Broich, K., Burkauskas, J., Davies, S. J. C., et al. (2024) · World Psychiatry
Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesMental Health Treatment and Access
Cited by 46
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free